New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study

References

• Tao Y, Wang M, Chen E, et al. Liver regeneration: analysis of the main relevant signaling molecules. Mediators Inflamm. 2017;2017:4256352.
   PubMed Web of Science ®Google Scholar
• Dewhurst MR, Ow JR, Zafer G, et al. Loss of hepatocyte cell division leads to liver inflammation and fibrosis. PLoS Genet. 2020;16(11):e1009084.
   PubMed Web of Science ®Google Scholar
• Tan Z, Sun H, Xue T, et al. Liver fibrosis: therapeutic targets and advances in drug therapy. Front Cell Dev Biol. 2021;9:2622.
   Web of Science ®Google Scholar
• Dickson JC, Liese AD, Lorenzo C, et al. Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. BMC Gastroenterol. 2015;15(1):1–9.
   PubMedGoogle Scholar
• Hoffmann K, Nagel AJ, Tanabe K, et al. Markers of liver regeneration—the role of growth factors and cytokines: a systematic review. BMC Surg.;2020;20(1):1–15.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Wang B. The gut-liver axis in health and disease: the role of gut microbiota-derived signals in liver injury and regeneration. Front Immunol. 2021;12:775526.
   PubMed Web of Science ®Google Scholar
• Yu J. The functional role and translational potential of gut microbiota and microbial metabolites in liver diseases. J Gastroenterol Hepatol. 2022;37(1):5–6.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Zhang X, et al. Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front Microbiol. 2017;8:2222.
   PubMed Web of Science ®Google Scholar
• Li F, McClain CJ, Feng W. Microbiome dysbiosis and alcoholic liver disease. Liver Res. 2019;3(3-4):218–226.
   PubMedGoogle Scholar
• Bao Q, Yu L, Chen D, et al. Variation in the gut microbial community is associated with the progression of liver regeneration. Hepatol Res. 2020;50(1):121–136.
   PubMed Web of Science ®Google Scholar
• Alwahsh SM, Gebhardt R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Arch Toxicol. 2017;91(4):1545–1563.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang W, Zhang R, et al. Lactulose accelerates liver regeneration in rats by inducing hydrogen. J Surg Res. 2015;195(1):128–135.
   PubMed Web of Science ®Google Scholar
• Xu Z, Jiang N, Xiao Y, et al. The role of gut microbiota in liver regeneration. Front Immunol. 2022;13:1003376.
   PubMed Web of Science ®Google Scholar
• Howarth GS, Wang H. Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients. 2013;5(1):58–81.
   PubMed Web of Science ®Google Scholar
• Li R, Mao Z, Ye X, et al. Human gut microbiome and liver diseases: from correlation to causation. Microorganisms. 2021;9(5):1017.
   PubMed Web of Science ®Google Scholar
• Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14(3):141–153.
   PubMed Web of Science ®Google Scholar
• Allaire JM, Crowley SM, Law HT, et al. The intestinal epithelium: central coordinator of mucosal immunity. Trends Immunol. 2018;39(9):677–696.
   PubMed Web of Science ®Google Scholar
• Forbes SJ, Newsome PN. Liver regeneration - mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol. 2016;13(8):473–485.
   PubMed Web of Science ®Google Scholar
• Sakle NS, More SA, Mokale SN. A network pharmacology-based approach to explore potential targets of Caesalpinia pulcherima: an updated prototype in drug discovery. Sci Rep. 2020;10(1):16.
   PubMed Web of Science ®Google Scholar
• Ding Y, Chen M, Wang Q, et al. Integrating pharmacology and microbial network analysis with experimental validation to reveal the mechanism of composite sophora colon-soluble capsule against ulcerative colitis. Evid Based Complement Alternat Med. 2020;2020:9521073.
   PubMed Web of Science ®Google Scholar
• Liu HX, Keane R, Sheng L, et al. Implications of microbiota and bile acid in liver injury and regeneration. J Hepatol. 2015;63(6):1502–1510.
   PubMed Web of Science ®Google Scholar
• Keiser MJ, Setola V, Irwin JJ, et al. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175–181.
   PubMed Web of Science ®Google Scholar
• Gfeller D, Grosdidier A, Wirth M, et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 2014;42(W1):W32–W38.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778–2786.
   PubMed Web of Science ®Google Scholar
• Shityakov S, Förster C. In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter. Adv Appl Bioinform Chem. 2014;7:23–36.
   PubMedGoogle Scholar
• Daina A, Zoete V. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016;11(11):1117–1121.
   PubMed Web of Science ®Google Scholar
• Lamothe SM, Guo J, Li W, et al. The human ether-a-go-go-related gene (hERG) potassium channel represents an unusual target for protease-mediated damage. J Biol Chem. 2016;291(39):20387–20401.
   PubMed Web of Science ®Google Scholar
• Mulliner D, Schmidt F, Stolte M, et al. Computational models for human and animal hepatotoxicity with a global application scope. Chem Res Toxicol. 2016;29(5):757–767.
   PubMed Web of Science ®Google Scholar
• Xu C, Cheng F, Chen L, et al. In silico prediction of chemical Ames mutagenicity. J Chem Inf Model. 2012;52(11):2840–2847.
   PubMed Web of Science ®Google Scholar
• Alves VM, Muratov E, Fourches D, et al. Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization. Toxicol Appl Pharmacol. 2015;284(2):273–280.
   PubMed Web of Science ®Google Scholar
• Lei T, Li Y, Song Y, et al. ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling. J Cheminform. 2016;8:6.
   PubMed Web of Science ®Google Scholar
• Xu Y, Dai Z, Chen F, et al. Deep learning for drug-induced liver injury. J Chem Inf Model. 2015;55(10):2085–2093.
   PubMed Web of Science ®Google Scholar
• Dong J, Wang NN, Yao ZJ, et al. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform. 2018;10(1) : 1–11.
   PubMedGoogle Scholar
• Lee AY, Park W, Kang TW, et al. Network pharmacology-based prediction of active compounds and molecular targets in Yijin-Tang acting on hyperlipidaemia and atherosclerosis. J Ethnopharmacol. 2018;221:151–159.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Sun YZ, Gao XH, et al. Integrated bioinformatic analysis of differentially expressed genes and signaling pathways in plaque psoriasis. Mol Med Rep. 2019;20(1):225–235.
   PubMed Web of Science ®Google Scholar
• Nougayrède JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313(5788):848–851.
   PubMed Web of Science ®Google Scholar
• Auvray F, Perrat A, Arimizu Y, et al. Insights into the acquisition of the pks island and production of colibactin in the Escherichia coli population. Microbial Genomics. 2021;7(5) : 1–16.
   Google Scholar
• Quinn RJ, Carroll AR, Pham NB, et al. Developing a drug-like natural product library. J Nat Prod. 2008;71(3):464–468.
   PubMed Web of Science ®Google Scholar
• Rehan M, Mahmoud MM, Tabrez S, et al. Exploring flavonoids for potential inhibitors of a cancer signaling protein PI3Kγ kinase using computational methods. Anticancer Res. 2020;40(8):4547–4556.
   PubMed Web of Science ®Google Scholar
• Du LY, Zhao M, Xu J, et al. Identification of the metabolites of myricitrin produced by human intestinal bacteria in vitro using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Expert Opin Drug Metab Toxicol. 2014;10(7):921–931.
   PubMed Web of Science ®Google Scholar
• Geng Y, Sun Q, Li W, et al. The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice. MNFR. 2017;61(4): 1-9.
   Web of Science ®Google Scholar
• Wang X, Sun Y, Li P, et al. The protective effects of myricetin against acute liver failure via inhibiting inflammation and regulating oxidative stress via Nrf2 signaling. Nat Prod Res. 2022; 36(24): 1–5.
   Google Scholar
• Oh JH, Sinn DH, Choi GS, et al. Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria. Ann Surg Treat Res. 2020;99(4):238–246.
   PubMed Web of Science ®Google Scholar
• Jin S, Fu Q, Wuyun G, et al. Management of post-hepatectomy complications. World J Gastroenterol. 2013;19(44):7983–7991.
   PubMed Web of Science ®Google Scholar
• Wu JP, Tsai CC, Yeh YL, et al. Silymarin accelerates liver regeneration after partial hepatectomy. Evid Based Complement Alternat Med. 2015;2015:603529.
   PubMed Web of Science ®Google Scholar
• Ahn YM, Lee GS, Yang HG, et al. Antioxidant and proliferative activity of the fruit extract of Lycium chinense in regenerating liver after partial hepatectomy in rats. Biomed Res. 2018;29(12):2590–2596.
   Google Scholar
• Cui C, Enosawa S, Matsunari H, et al. Natural flavonol, myricetin, enhances the function and survival of cryopreserved hepatocytes in vitro and in vivo. IJMS. 2019;20(24):6123.
   Google Scholar
• Chen XJ, Liu WJ, Wen ML, et al. Ameliorative effects of compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats. Sci Rep. 2017 7:41144.
   PubMed Web of Science ®Google Scholar
• Elshamy AI, Ammar NM, Hassan HA, et al. Topical wound healing activity of myricetin isolated from Tecomaria capensis v. aurea. Molecules. 2020;25(21):4870.
   PubMed Web of Science ®Google Scholar
• Ding L, Gu S, Zhou B, et al. Ginsenoside compound K enhances fracture healing via promoting osteogenesis and angiogenesis. Front Pharmacol. 2022;13:855393.
   PubMed Web of Science ®Google Scholar
• Wang R, Wang Y, Wu J, et al. Resveratrol targets AKT1 to inhibit inflammasome activation in cardiomyocytes under acute sympathetic stress. Front Pharmacol. 2022;13:818127.
   PubMed Web of Science ®Google Scholar
• Romero-Becerra R, Santamans AM, Folgueira C, et al. p38 MAPK pathway in the heart: new insights in health and disease. IJMS. 2020;21(19):7412.
   Google Scholar
• Hogaboam CM, Bone‐Larson CL, Steinhauser ML, et al. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. FASEB J. 1999;13(12):1565–1574.
   PubMed Web of Science ®Google Scholar
• Colletti LM, Green M, Burdick MD, et al. Proliferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo. Undefined. 1998;10:248–257.
   Google Scholar
• Kuboki S, Shin T, Huber N, et al. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice. Hepatology. 2008;48(4):1213–1223.
   PubMed Web of Science ®Google Scholar
• Stefanovic L, Stefanovic B. Mechanism of direct hepatotoxic effect of KC chemokine: sequential activation of gene expression and progression from inflammation to necrosis. J Interferon Cytokine Res. 2006;26(10):760–770.
   PubMed Web of Science ®Google Scholar
• Kay AM, Simpson CL, Stewart JA. The role of AGE/RAGE signaling in diabetes-mediated vascular calcification. J Diabetes Res. 2016;2016:6809703.
   PubMed Web of Science ®Google Scholar
• Lei Y, Huang T, Su M, et al. Expression and distribution of immunoglobulin G in the normal liver, hepatocarcinoma and postpartial hepatectomy liver. Lab Invest. 2014;94(11):1283–1295.
   PubMed Web of Science ®Google Scholar
• Seki E, Park E, Fujimoto J. Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis. Hepatol Res. 2011;41(7):597–610.
   PubMed Web of Science ®Google Scholar
• Ramos-Martinez E, Ramos-Martínez I, Molina-Salinas G, et al. The role of prolactin in central nervous system inflammation. Rev Neurosci. 2021;32(3):323–340.
   PubMed Web of Science ®Google Scholar
• Guillot A, Gasmi I, Brouillet A, et al. Interleukins-17 and 27 promote liver regeneration by sequentially inducing progenitor cell expansion and differentiation. Hepatol Commun. 2018;2(3):329–343.
   PubMed Web of Science ®Google Scholar
• Kimura T, Sakaida I, Terai S, et al. Inhibition of tumor necrosis factor-α production retards liver regeneration after partial hepatectomy in rats. Biochem Biophys Res Commun. 1997;231(3):557–560.
   PubMed Web of Science ®Google Scholar
• Ozkurt M, Hellwig-Bürgel T, Depping R, et al. miR663 prevents Epo inhibition caused by TNF-alpha in normoxia and hypoxia. Int J Endocrinol. 2021;2021:3670499.
   PubMed Web of Science ®Google Scholar
• Fujita J, Marino MW, Wada H, et al. Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice. Surgery. 2001;129(1):48–54.
   PubMed Web of Science ®Google Scholar
• Taniguchi E, Sakisaka S, Matsuo K, et al. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem. 2001;49(1):121–130.
   PubMed Web of Science ®Google Scholar
• Kono H, Fujii H, Suzuki-Inoue K, et al. The platelet-activating receptor C-type lectin receptor-2 plays an essential role in liver regeneration after partial hepatectomy in mice. J Thromb Haemost. 2017;15(5):998–1008.
   PubMed Web of Science ®Google Scholar
• Carver RS, Stevenson MC, Scheving LA, et al. Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology. 2002;123(6):2017–2027.
   PubMed Web of Science ®Google Scholar
• Rosario D, Boren J, Uhlen M, et al. Systems biology approaches to understand the host–microbiome interactions in neurodegenerative diseases. Front Neurosci. 2020;14:716.
   PubMed Web of Science ®Google Scholar